4.8 Article

Activation of Toll-like Receptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory Responses

Journal

CELL REPORTS
Volume 9, Issue 5, Pages 1856-1870

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2014.10.067

Keywords

-

Categories

Funding

  1. Cancer Research Institute (CLIP award)
  2. Ludwig Institute for Cancer Research
  3. Alliance for Lupus Research
  4. Melanoma Research Alliance
  5. Bill and Melinda Gates Foundation
  6. American Cancer Society
  7. NIH [R01 AI071078, CCSG 5 P30 CA16087, R37 AI048638, R37 DK057665, U19 AI057266, U19 AI090023]
  8. NIH/NIAMS [5K99AR062595]

Ask authors/readers for more resources

Matrix metalloproteinase-2 (MMP-2) is involved in several physiological mechanisms, including wound healing and tumor progression. We show that MMP-2 directly stimulates dendritic cells (DCs) to both upregulate OX40L on the cell surface and secrete inflammatory cytokines. The mechanism underlying DC activation includes physical association with Toll-like receptor-2 (TLR2), leading to NF-kappa B activation, OX40L upregulation on DCs, and ensuing TH2 differentiation. Significantly, MMP-2 polarizes T cells toward type 2 responses in vivo, in a TLR2-dependent manner. MMP-2-dependent type 2 polarization may represent a key immune regulatory mechanism for protection against a broad array of disorders, such as inflammatory, infectious, and autoimmune diseases, which can be hijacked by tumors to evade immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice

Alexandra C. Walls, Laura A. VanBlargan, Kai Wu, Angela Choi, Mary Jane Navarro, Diana Lee, Laura Avena, Daniela Montes Berrueta, Minh N. Pham, Sayda Elbashir, John C. Kraft, Marcos C. Miranda, Elizabeth Kepl, Max Johnson, Alyssa Blackstone, Kaitlin Sprouse, Brooke Fiala, Megan A. O'Connor, Natalie Brunette, Prabhu S. Arunachalam, Lisa Shirreff, Kenneth Rogers, Lauren Carter, Deborah H. Fuller, Francois Villinger, Bali Pulendran, Michael S. Diamond, Darin K. Edwards, Neil P. King, David Veesler

Summary: The use of BALB/c mice as an animal model to study neutralizing antibody responses against SARS-CoV-2 variants of concern (VOCs) may not accurately reflect the breadth and potency of responses observed in non-human primates or humans vaccinated with various vaccine platforms.

CELL REPORTS (2022)

Article Immunology

Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination

Slim Fourati, Lewis E. Tomalin, Matthew P. Mule, Daniel G. Chawla, Bram Gerritsen, Dmitry Rychkov, Evan Henrich, Helen E. R. Miller, Thomas Hagan, Joann Diray-Arce, Patrick Dunn, Ofer Levy, Raphael Gottardo, Minnie M. Sarwal, John S. Tsang, Mayte Suarez-Farinas, Bali Pulendran, Steven H. Kleinstein, Rafick-Pierre Sekaly

Summary: Several studies have shown that the pre-vaccination immune state is associated with the antibody response to vaccination. This study identified a common pre-vaccination signature and mechanisms that could predict the immune response across 13 different vaccines. The results suggest that the transcriptional state of the immune system can determine responsiveness to vaccination.

NATURE IMMUNOLOGY (2022)

Article Immunology

SREBP signaling is essential for effective B cell responses

Wei Luo, Julia Z. Z. Adamska, Chunfeng Li, Rohit Verma, Qing Liu, Thomas Hagan, Florian Wimmers, Shakti Gupta, Yupeng Feng, Wenxia Jiang, Jiehao Zhou, Erika Valore, Yanli Wang, Meera Trisal, Shankar Subramaniam, Timothy F. Osborne, Bali Pulendran

Summary: Our previous study showed that the sterol regulatory binding protein (SREBP) pathway is associated with humoral immune response. We generated mice with specific deletion of SCAP, an essential regulator of SREBP signaling, in B cells or CD11c(+) antigen-presenting cells (APCs). Deletion of SCAP in CD11c(+) APCs had no impact on immune responses, whereas SREBP signaling in B cells was crucial for antibody responses and the development of immune cells. These studies reveal the regulatory role of sterol metabolism in humoral immunity.

NATURE IMMUNOLOGY (2023)

Correction Immunology

The persistence of memory: defining, engineering, and measuring vaccine durability (vol 23, pg 1665, 2022)

Amy C. Palin, Galit Alter, Shane Crotty, Ali H. Ellebedy, M. Chelsea Lane, F. Eun-Hyung Lee, Michela Locci, Angela Malaspina, Conrad Mallia, M. Juliana McElrath, Bali Pulendran, Anjali Singh, M. Patricia D'Souza

NATURE IMMUNOLOGY (2023)

Article Chemistry, Physical

A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2

Qian Yin, Wei Luo, Vamsee Mallajosyula, Yang Bo, Jing Guo, Jinghang Xie, Meng Sun, Rohit Verma, Chunfeng Li, Christian M. M. Constantz, Lisa E. E. Wagar, Jing Li, Elsa Sola, Neha Gupta, Chunlin Wang, Oliver Kask, Xin Chen, Xue Yuan, Nicholas C. C. Wu, Jianghong Rao, Yueh-hsiu Chien, Jianjun Cheng, Bali Pulendran, Mark M. M. Davis

Summary: This study uses a nanoparticle-based adjuvant to enhance immune responses against multiple variants of influenza and SARS-CoV-2, generating cross-reactive antibodies for both dominant and subdominant epitopes. The adjuvant shows promising implications for developing broadly protective vaccines, as it improves lymph node targeting, activates immune cells, and leads to broad immune responses. The adjuvanted vaccines successfully protect mice against viral challenges of different strains and enhance antibody responses to SARS-CoV-2 subunit vaccines against multiple viral variants.

NATURE MATERIALS (2023)

Article Cell Biology

Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2

Julia Z. Adamska, Rohit Verma, Shakti Gupta, Thomas Hagan, Florian Wimmers, Katharine Floyd, Qin Li, Erika V. Valore, Yanli Wang, Meera Trisal, Jose G. Vilches-Moure, Shankar Subramaniam, Carl R. Walkley, Mehul S. Suthar, Jin Billy Li, Bali Pulendran

Summary: Deletion of ADAR1 in CD11c+ APCs leads to changes in immune response, including enrichment of inflammatory cells, increased activated tissue resident memory T cells, and broad changes in antiviral transcriptional signature. These changes can be partially reversed by blocking IFNAR1 signaling and promote early resistance against SARS-CoV-2 infection.

CELL REPORTS (2023)

Article Multidisciplinary Sciences

Progress in vaccine development for infectious diseases-a Keystone Symposia report

Jennifer Cable, Barney S. Graham, Richard A. Koup, Robert A. Seder, Katalin Kariko, Norbert Pardi, Dan H. Barouch, Bhawna Sharma, Susanne Rauch, Raffael Nachbagauer, Mattias N. E. Forsell, Michael Schotsaert, Ali H. Ellebedy, Karin Lore, Darrell J. Irvine, Emily Pilkington, Siri Tahtinen, Elizabeth A. Thompson, Yanis Feraoun, Neil P. King, Kevin Saunders, Galit Alter, Syed M. Moin, Kwinten Sliepen, Gunilla B. Karlsson Hedestam, Hedda Wardemann, Bali Pulendran, Nicole A. Doria-Rose, Wan-Ting He, Jennifer A. Juno, Sila Ataca, Adam K. Wheatley, Jason S. McLellan, Laura M. Walker, Julia Lederhofer, Lisa C. Lindesmith, Holger Wille, Peter J. Hotez, Linda-Gail Bekker

Summary: The COVID-19 pandemic has highlighted the importance of vaccines in public health and advancements in vaccine technology are vital for preventing infectious diseases. While many diseases still lack effective vaccines, recent developments in fields like immunology and structural biology may lead to breakthroughs in vaccination and enhance preparedness for future pandemics.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2023)

Article Immunology

Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+T cell responses post SARS-CoV-2 infection

Fei Gao, Vamsee Mallajoysula, Prabhu S. Arunachalam, Kattria van der Ploeg, Monali Manohar, Katharina Roltgen, Fan Yang, Oliver Wirz, Ramona Hoh, Emily Haraguchi, Ji-Yeun Lee, Richard Willis, Vasanthi Ramachandiran, Jiefu Li, Karan Raj Kathuria, Chunfeng Li, Alexandra S. Lee, Mihir M. Shah, Sayantani B. Sindher, Joseph Gonzalez, John D. Altman, Taia T. Wang, Scott D. Boyd, Bali Pulendran, Prasanna Jagannathan, Kari C. Nadeau, Mark M. Davis

Summary: T cells play a crucial role in the immune response to SARS-CoV-2, but their behavior after infection and vaccination is not well understood. This study examined the T cell responses of subjects receiving the Pfizer/BioNTech BNT162b2 vaccine. Vaccination induced strong spike-specific T cell responses for both CD4+ and CD8+ T cells, with CD4+ responses peaking 1 week after the second dose and CD8+ responses peaking 2 weeks later. These T cell responses were higher than those observed in COVID-19 patients. Additionally, prior SARS-CoV-2 infection was found to decrease CD8+ T cell activation and expansion, suggesting an influence of previous infection on the T cell response to vaccination.

IMMUNITY (2023)

Correction Multidisciplinary Sciences

Systems vaccinology of the BNT162b2 mRNA vaccine in humans (vol 596, pg 410, 2021)

Prabhu S. Arunachalam, Madeleine K. D. Scott, Thomas Hagan, Chunfeng Li, Yupeng Feng, Florian Wimmers, Lilit Grigoryan, Meera Trisal, Venkata Viswanadh Edara, Lilin Lai, Sarah Esther Chang, Allan Feng, Shaurya Dhingra, Mihir Shah, Alexandra S. Lee, Sharon Chinthrajah, Sayantani B. Sindher, Vamsee Mallajosyula, Fei Gao, Natalia Sigal, Sangeeta Kowli, Sheena Gupta, Kathryn Pellegrini, Gregory Tharp, Sofia Maysel-Auslender, Sydney Hamilton, Hadj Aoued, Kevin Hrusovsky, Mark Roskey, Steven E. Bosinger, Holden T. Maecker, Scott D. Boyd, Mark M. Davis, Paul J. Utz, Mehul S. Suthar, Purvesh Khatri, Kari C. Nadeau, Bali Pulendran

NATURE (2023)

Article Multidisciplinary Sciences

Circular RNA vaccine induces potent T cell responses

Laura Amaya, Lilit Grigoryan, Zhijian Li, Audrey Lee, Paul A. Wender, Bali Pulendran, Howard Y. Chang

Summary: Circular RNAs (circRNAs) are highly stable RNAs that can be engineered to provide durable protein expression. This study shows that circRNA encoding antigenic protein sequences delivered by a charge-altering releasable transporter can serve as both an adjuvant and an immunogen, inducing potent cellular immunity and leading to tumor clearance as a therapeutic vaccine. These results suggest the potential utility of engineered circRNAs for the development of vaccines and therapeutics.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Cell Biology

Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine

Yupeng Feng, Meng Yuan, John M. Powers, Mengyun Hu, Jennifer E. Munt, Prabhu S. Arunachalam, Sarah R. Leist, Lorenza Bellusci, JungHyun Kim, Kaitlin R. Sprouse, Lily E. Adams, Sumana Sundaramurthy, Xueyong Zhu, Lisa M. Shirreff, Michael L. Mallory, Trevor D. Scobey, Alberto Moreno, Derek T. O'Hagan, Harry Kleanthous, Francois J. Villinger, David Veesler, Neil P. King, Mehul S. Suthar, Surender Khurana, Ralph S. Baric, Ian A. Wilson, Bali Pulendran

Summary: This study identified highly potent monoclonal antibodies (mAbs) from macaques vaccinated with AS03-adjuvanted monovalent subunit vaccines that neutralized multiple sarbecoviruses. The antibodies generated from antigen-specific memory B cells (MBCs) exhibited increasing potency and breadth over a period of 8-15 months after vaccination. Some of the antibodies also showed neutralizing activity against the SARS-CoV-2 BA.1 variant. Crystallography studies revealed the molecular basis of the broad and potent neutralization.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Multidisciplinary Sciences

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

Payton A. -B. Weidenbacher, Mrinmoy Sanyal, Natalia Friedland, Shaogeng Tang, Prabhu S. Arunachalam, Mengyun Hu, Ozan S. Kumru, Mary Kate Morris, Jane Fontenot, Lisa Shirreff, Jonathan Do, Ya-Chen Cheng, Gayathri Vasudevan, Mark B. Feinberg, Francois J. Villinger, Carl Hanson, Sangeeta B. Joshi, David B. Volkin, Bali Pulendran, Peter S. Kim

Summary: While the development of COVID-19 vaccines has been successful, there is a need for a globally available vaccine that provides longer-lasting immunity against current and future variants of concern. One potential vaccine candidate is DCFHP, a protein-nanoparticle vaccine formulated with aluminum hydroxide as the adjuvant. It has shown promising results in eliciting potent and durable neutralizing antibodies in non-human primates against known variants and can be produced in large quantities. DCFHP has the potential to be used as a booster vaccine or as a primary vaccine for pediatric use.

NATURE COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth

Florian Wimmers, Allison R. Burrell, Yupeng Feng, Hong Zheng, Prabhu S. Arunachalam, Mengyun Hu, Sara Spranger, Lindsay E. Nyhoff, Devyani Joshi, Meera Trisal, Mayanka Awasthi, Lorenza Bellusci, Usama Ashraf, Sangeeta Kowli, Katherine C. Konvinse, Emily Yang, Michael Blanco, Kathryn Pellegrini, Gregory Tharp, Thomas Hagan, R. Sharon Chinthrajah, Tran T. Nguyen, Alba Grifoni, Alessandro Sette, Kari C. Nadeau, David B. Haslam, Steven E. Bosinger, Jens Wrammert, Holden T. Maecker, Paul J. Utz, Taia T. Wang, Surender Khurana, Purvesh Khatri, Mary A. Staat, Bali Pulendran

Summary: This study used a multi-omics approach to investigate immunity to SARS-CoV2 in infants and young children. The results showed that infants mounted a robust mucosal immune response and had long-lasting antibody titers.
Article Medicine, Research & Experimental

Durability of immune responses to mRNA booster vaccination against COVID-19

Prabhu S. Arunachalam, Lilin Lai, Hady Samaha, Yupeng Feng, Mengyun Hu, Harold Sai-yin Hui, Bushra Wali, Madison Ellis, Meredith E. Davis-Gardner, Christopher Huerta, Kareem Bechnak, Sarah Bechnak, Matthew Lee, Matthew B. Litvack, Cecilia Losada, Alba Grifoni, Alessandro Sette, Veronika I. Zarnitsyna, Nadine Rouphael, Mehul S. Suthar, Bali Pulendran

Summary: The durability of serum antibody responses only marginally improves after booster immunizations with the Pfizer-BioNTech or Moderna mRNA vaccines.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Correction Medicine, General & Internal

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study (vol 83, 104208, 2022)

Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, Carly E. Milliren, Carolyn S. Calfee, Charles B. Cairns, Monica Kraft, Lindsey R. Baden, Albert C. Shaw, Florian Krammer, Harm van Bakel, Denise A. Esserman, Shanshan Liu, Ana Fernandez Sesma, Viviana Simon, David A. Hafler, Ruth R. Montgomery, Steven H. Kleinstein, Ofer Levy, Chris Bime, Elias K. Haddad, David J. Erle, Bali Pulendran, Kari C. Nadeau, Mark M. Davis, Catherine L. Hough, William B. Messer, Nelson I. Agudelo Higuita, Jordan P. Metcalf, Mark A. Atkinson, Scott C. Brakenridge, David Corry, Farrah Kheradmand, Lauren I. R. Ehrlich, Esther Melamed, Grace A. Mccomsey, Rafick Sekaly, Joann Diray-Arce, Bjoern Peters, Alison D. Augustine, Elaine F. Reed, Matthew C. Altman, Patrice M. Becker, Nadine Rouphael

EBIOMEDICINE (2023)

No Data Available